Inositol metabolism mononuclear leucocytes patients atopic dermatitis Elevated activity cyclic adenosine monophosphate-specific phosphodiesterase PDE peripheral blood mononuclear MNLs patients atopic dermatitis AD potential interactions cyclic nucleotide inositol secondary messenger systems differences inositol uptake metabolism atopic normal MNLs difference uptake inositol MNL atopic patients non-atopic control subjects stimulation MNLs concanavalin metabolism inositol controls atopic MNLs mean percentage rise fraction baseline level atopics controls Diminished inositol metabolism atopic MNLs reduced cell-mediated immunity atopic state 